Find clinical trials for Pancreatic Cancer in Baltimore, MD
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Baltimore, MD, USA:
This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions invol...
Phase 2
Baltimore, Maryland, United States and 9 other locations
and/or radiation, as well as patients with metastatic colorectal cancer who have exposure to 2 or more lines of chemotherapy, to evaluate sa...
Phase 1
Baltimore, Maryland, United States
The study is a first-in-human, Phase I study to assess the safety of ProAgio in participants with advanced solid tumor malignancies includin ...
Phase 1
Bethesda, Maryland, United States
or metastatic mismatch repair-proficient (MMR-p) colorectal cancer (mCRC) or unresectable or metastatic MMR-p pancreatic ductal ade...
Phase 1
Baltimore, Maryland, United States
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer...
Phase 2
Fairfax, Virginia, United States and 16 other locations
The purpose of this study is to determine the optimal dose of AGEN2373 that is safe when given in combination with balstilimab and Pancreatic...
Phase 1, Phase 2
Baltimore, Maryland, United States
phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...
Phase 1
Fairfax, Virginia, United States and 65 other locations
low dose chemotherapy with gemcitabine, nab-paclitaxel, capecitabine, cisplatin, and irinotecan (GAX-CI) in patients with untreated metastatic pancreatic...
Phase 2
Baltimore, Maryland, United States
This is a Phase 1b/2, open-label, multi-center, competitive enrollment and dose-escalation study of HCW9218 in patients with advanced/metastatic pancreatic...
Phase 1, Phase 2
Bethesda, Maryland, United States and 4 other locations
(an anti-PD-1 antibody) in combination with SX-682 (a CXCR1/2 inhibitor) in subjects with newly diagnosed and surgically resectable pancreatic...
Phase 2
Baltimore, Maryland, United States
Clinical trials
Research sites
Resources
Legal